Xenon Pharmaceuticals Inc.
NASDAQXenon Pharmaceuticals reported Q2 results on August 6 and the stock fell roughly 1.4% the following day — a muted reaction that leaves the broader setup more interesting than the print itself. The sharpest change in positioning this week is a meaningful retreat in short interest. Bears have covered ground steadily over the past month, cutting short positions by nearly 5%…
XENE short interest surges 44% in one week to 7.6% of float, as availability plummets 83% amid rising borrow costs.
Snapshot as of 26 Aug 2026
Xenon Pharmaceuticals reported Q2 results on August 6 and the stock fell roughly 1.4% the following day — a muted reaction that leaves the broader setup more interesting than the print itself. The sharpest change in…
Xenon Pharmaceuticals enters its June 2 earnings call in an unusual position: short sellers have been cutting exposure for a month, analysts keep raising targets, and yet the stock trades roughly 14% below the Street…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for XENE — free to start on ORTEX.
Sign up for free →Open XENE on ORTEX